Mahmoud Alameddine

Mahmoud Alameddine practices at Ottumwa Regional Health Center in Ottumwa, Iowa, part of Lifepoint Health.

Mahmoud Alameddine's NPI, 1730595778, was assigned on July 10, 2014. Mahmoud Alameddine graduated from Beirut Arab University Faculty of Medicine in 2003. Mahmoud Alameddine holds Iowa license MD-44961.

Mahmoud Alameddine's primary practice is Ottumwa Regional Health Center, at 1001 E Pennsylvania, Ottumwa, IA 52501 in Wapello County. The practice phone is (641) 682-7511.

Mahmoud Alameddine's primary practice is Ottumwa Regional Health Center in Ottumwa, Iowa, part of Lifepoint Health. Mahmoud Alameddine is also affiliated with University of Iowa Health Care Medical Center. The medical group on file is Ottumwa Health Group. Dmand AI also links Mahmoud Alameddine to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mahmoud Alameddine practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Mahmoud Alameddine's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Mahmoud Alameddine's licenses on file in 3 states: Iowa, Florida and Ohio.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Mahmoud Alameddine treats.

CMS data shows 1,319 Medicare services from Mahmoud Alameddine across 17 procedure codes in 2024, for 459 Medicare patients. Medicare paid $88,779 for them.

CMS counts 459 Medicare patients who saw Mahmoud Alameddine in 2024. The largest group is 65 to 74, with 237 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mahmoud Alameddine's median patient age at 71, with 24% women.

In 2024, Mahmoud Alameddine wrote 1,776 Medicare Part D claims for 439 patients. 92% of them were for generic drugs. CMS names the drug for 1,670 of them, across 17 drugs with 11 or more claims each, at $108,055 in total drug cost. In 2023, CMS named 1,570 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Mahmoud Alameddine for performance year 2024, reported as part of a group. Mahmoud Alameddine accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 35 papers to Mahmoud Alameddine, published from 2017 to 2023. 2018 was the busiest year, with 8. The most frequent topics are Urinary Bladder Neoplasms, Cystectomy and Transgender Persons. Mahmoud Alameddine has published most often in Curr Urol Rep. Mahmoud Alameddine's most frequent co-authors are Joshua Stephen Jue, MD, Gaetano Ciancio, MBA, MD and Chad Ryan Ritch, MD.

CMS Open Payments shows 246 general payments to Mahmoud Alameddine from 27 drug and device companies from 2018 to 2025. Education make up the largest share, 60% of the total. Intuitive Surgical, Inc. paid the most, $15,355.

Mahmoud Alameddine graduated from Beirut Arab University Faculty of Medicine in 2003.

Mahmoud Alameddine is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.